Zobrazeno 1 - 10
of 366
pro vyhledávání: '"S. Berghoff"'
Autor:
Julia M. Berger, Felix Lötsch, Anna S. Berghoff, Wolfgang W. Lamm, Matthias Preusser, Georg Jeryczynski
Publikováno v:
Medical Mycology Case Reports, Vol 45, Iss , Pp 100660- (2024)
Here, we present the case of a patient with a metastatic neuroendocrine tumor with cytologically negative ascites treated for spontaneous bacterial peritonitis (SBP). Ascitic cultures remained negative for bacterial growth but were positive for Candi
Externí odkaz:
https://doaj.org/article/f99ee9dc05b6476586783caa3a831231
Autor:
Maximilian J. Mair, Agnieszka Maj-Hes, Alina Nussbaumer-Pröll, Rainer Puhr, Agnieszka Christenheit, Marlene Troch, Hannah C. Puhr, Angelika M. Starzer, Ariane Steindl, Sabine Eberl, Helmuth Haslacher, Thomas Perkmann, Christoph Minichsdorfer, Gerald W. Prager, Wolfgang W. Lamm, Anna S. Berghoff, Barbara Kiesewetter, Markus Zeitlinger, Matthias Preusser, Markus Raderer
Publikováno v:
Infectious Agents and Cancer, Vol 18, Iss 1, Pp 1-10 (2023)
Abstract Background Patients with cancer are at high risk for severe courses of COVID-19. Based on (pre-)clinical data suggesting a potential protective effect due to the immunomodulating properties of azithromycin, we have initiated a prospective ra
Externí odkaz:
https://doaj.org/article/ea5d091cfe5e4460a474548a11cbcfca
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/f9cc4c9a8c4a4ab49d1d87aceeea0fc1
Autor:
Joshua Tobias, Mirjana Drinić, Sandra Högler, Katharina Ambroz, Karin Baier, Petra Kodajova, Erwin Tomasich, Anna S. Berghoff, Anna Schmid, Erika Garner-Spitzer, Lukas Kenner, Michael Kundi, Christoph C. Zielinski, Ursula Wiedermann
Publikováno v:
Translational Oncology, Vol 19, Iss , Pp 101378- (2022)
In pre-clinical and clinical settings, active immunization with a Her-2/neu vaccine (HerVaxx), comprising B-cell peptide from Trastuzumab binding site, has been shown to reduce primary tumor growth via induction of polyclonal anti-tumor immune respon
Externí odkaz:
https://doaj.org/article/7d599b48fb6542b08b70ca40b801fdb5
Autor:
Barbara Kiesel, Carina M. Thomé, Tobias Weiss, Asgeir S. Jakola, Amélie Darlix, Alessia Pellerino, Julia Furtner, Johannes Kerschbaumer, Christian F. Freyschlag, Wolfgang Wick, Matthias Preusser, Georg Widhalm, Anna S. Berghoff
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Neurosurgical resection represents an important treatment option in the modern, multimodal therapy approach of brain metastases (BM). Guidelines for perioperative imaging exist for primary brain tumors to guide postsurgical treatm
Externí odkaz:
https://doaj.org/article/a3e63d5e4b7846f9a734dfbf3beba256
Autor:
Rasheed Zakaria, Yin Jie Chen, David M. Hughes, Sumei Wang, Sanjeev Chawla, Harish Poptani, Anna S. Berghoff, Matthias Preusser, Michael D. Jenkinson, Suyash Mohan
Publikováno v:
Cancer Imaging, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Brain metastases are common in clinical practice. Many clinical scales exist for predicting survival and hence deciding on best treatment but none are individualised and none use quantitative imaging parameters. A multicenter stud
Externí odkaz:
https://doaj.org/article/ae8f1cff7b56481584df7e8c82b29984
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
The introduction of immune checkpoint inhibitors has changed the therapeutic possibilities for various cancer types. However, despite the success in some entities, a significant fraction of patients does not respond to immune checkpoint inhibitors. A
Externí odkaz:
https://doaj.org/article/493a286c7fba4339b351964705b3148d
Autor:
Matthias Preusser, Leonhard Müllauer, Anna S Berghoff, Sebastian Bauer, Gerwin Heller, Thomas Brodowicz, Wolfgang Lamm, Katharina Feldmann, Angelika M Starzer, Rainer Hamacher, Erwin Tomasich, Teresa Hatziioannou, Stefan Traint, Iris M Noebauer-Huhmann, Julia Furtner, Gabriele Amann, Hans-Ulrich Schildhaus
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Some sarcomas respond to immune checkpoint inhibition, but predictive biomarkers are unknown. We analyzed tumor DNA methylation profiles in relation to immunological parameters and response to anti-programmed cell death 1 (anti-PD-1) immun
Externí odkaz:
https://doaj.org/article/a79916ad1b1542e9b504874a3913dd32
Autor:
Maximilian J. Mair, Rupert Bartsch, Emilie Le Rhun, Anna S. Berghoff, Priscilla K. Brastianos, Javier Cortes, Hui K. Gan, Nancy U. Lin, Andrew B. Lassman, Patrick Y. Wen, Michael Weller, Martin van den Bent, Matthias Preusser
Publikováno v:
Nature Reviews Clinical Oncology. 20:372-389
Antibody–drug conjugates (ADCs), a class of targeted cancer therapeutics combining monoclonal antibodies with a cytotoxic payload via a chemical linker, have already been approved for the treatment of several cancer types, with extensive clinical d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f719b8a742aa6859a0fc1f389ab55895
https://doi.org/10.1038/s41571-023-00756-z
https://doi.org/10.1038/s41571-023-00756-z
Autor:
Elisabeth S. Bergen, Alexander Friedrich, Peter Scherleitner, Pedro Ferreira, Barbara Kiesel, Georg Widhalm, Barbara Kiesewetter, Franziska Eckert, Gerald W. Prager, Matthias Preusser, Anna S. Berghoff
Publikováno v:
Clinical & Experimental Metastasis. 40:177-185
While colorectal and gastroesophageal cancer represent the two gastrointestinal (GI) tumor entities with the highest incidence of brain metastatic (BM) disease, data on the clinical course of BM patients from hepatopancreatobiliary malignancies are r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7e367be9c91e737edd7f1472ebec978
https://doi.org/10.1007/s10585-023-10201-1
https://doi.org/10.1007/s10585-023-10201-1